Table 1.

Frequencies of KIR, KIRL and KIR/KIRL combinations in neuroblastoma patients (n = 53).

		Patients
	Gene	N	%
Activating KIR	2DS1	20	38
	2DS2	26	49
	2DS3*	14	27
	2DS4	53	100
	2DS5*	15	29
	3DS1	18	34
Inhibitory KIR	2DL1	51	96
	2DL2	26	49
	2DL3*	47	90
	3DL1	53	100
KIRL*	HLA-C1	45	87
	HLA-C2	34	65
	HLA-Bw4	41	79
2DL1/HLA-C2**	match	32	62
	mismatch	18	35
2DL2/HLA-C1	match	22	42
	mismatch	3	6
2DL3/HLA-C1	match	40	77
	mismatch	7	13
3DL1/HLA-Bw4**	match	41	77
	mismatch	11	21

^*DNA samples of 52 patients were available for analysis.

^**Due to missing DNA of one patient for KIRL analysis, the total number of KIR/KIRL combinations is reduced by n = 1.